Navigation Links
New Cancer Classification System Might Boost Patient Outcomes
Date:8/7/2014

THURSDAY, Aug. 7, 2014 (HealthDay News) -- Changes to the way cancers are classified could lead to more accurate diagnoses and perhaps more effective treatments in about one in 10 cancer patients, new research suggests.

Typically, cancers are categorized according to the tissue in which they originated, such as breast, bladder or kidney cancer. But tissues are composed of different types of cells.

In this study, researchers who analyzed more than 3,500 tumor samples of 12 different cancer types concluded that defining tumors by their cellular and molecular features, rather than by the tissues in which they originated, would improve diagnoses in about 10 percent of cancer cases.

"This genomic study not only challenges our existing system of classifying cancers based on tissue type, but also provides a massive new data resource for further exploration, as well as a comprehensive list of the molecular features distinguishing each of the newly described cancer classes," study co-senior author Dr. Christopher Benz, professor at the Buck Institute for Research on Aging at the University of California, San Francisco, said in a university news release.

The study, published online Aug. 7 in the journal Cell, is part of The Cancer Genome Atlas initiative, which is led by the U.S. National Cancer Institute and U.S. National Human Genome Research Institute.

The researchers report particularly significant findings in bladder and breast cancers. They identified at least three different subtypes of bladder cancer, including one that was nearly identical to a form of non-small cell lung cancer called lung adenocarcinoma, and another most similar to squamous-cell cancers of the head and neck and of the lungs.

The findings may explain why bladder cancer patients "often respond very differently when treated with the same systemic therapy for their seemingly identical cancer type," Benz said.

The researchers confirmed known differences between two forms of breast cancers called basal-like and luminal. But they also discovered that these differences are significant and that basal-like breast cancers -- commonly referred to as triple-negative -- are a distinct class of tumor.

"What's amazing is that basal breast cancer is as different from luminal breast cancer as it is from, say, kidney cancer," study co-lead author Denise Wolf, a research scientist based in UCSF's Department of Laboratory Medicine, said in the news release.

Basal-like cancers are highly aggressive and more common among black and younger women.

"Even though these basal-like cancers arise in the breast, on the molecular level they have more in common with ovarian cancers and cancers of squamous-cell origin than with other subtypes of breast cancer," explained study co-lead author Christina Yau, a staff scientist at the Buck Institute and assistant professor of surgery at UCSF.

"This is the first time ever you've been able to point to important molecular features shared by basal breast cancer, and by squamous head-and-neck cancer and lung cancer," Wolf said.

"And the same is true of immune activation -- we found that different cancer types have very similar immune signatures, a factor that may be relevant clinically with the rise of new immune therapies," she added.

Further research could reveal that as many as 30 to 50 percent of cancers need to be reclassified, according to Benz.

"Although follow-up studies are needed to validate and refine this newly proposed cancer classification system, it will ultimately provide the biologic foundation for that era of personalized cancer treatment that patients and clinicians eagerly await," Benz believes.

More information

The U.S. National Library of Medicine has more about cancer.

SOURCE: University of California, San Fransciso, news release, Aug. 7, 2014

--


'/>"/>
Copyright©2014 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Cell mechanics may hold key to how cancer spreads and recurs
2. Sharp Rise in Risk With New Breast Cancer Gene, Scientists Say
3. NuvOx Pharma Begins Clinical Trial to Treat Brain Cancer
4. Gut microbiome analysis improved noninvasive colorectal cancer screening
5. Young Cancer Patients at Loma Linda University Children's Hospital Treated to an Afternoon of Fun with UCLA Football Players, Sponsored by Stater Bros
6. Gene increases risk of breast cancer to 1 in 3 by age 70
7. Daily Aspirin May Help Prevent Cancer, Study Shows
8. Cancer Diagnostics Universe Discussed in Comprehensive VPG Research Study Published at MarketPublishers.com
9. One in 10 Cancer Survivors Still Smoke Years Later, Study Finds
10. Study shows low uptake of colorectal cancer screening by African Americans in a Veterans Affairs healthcare network
11. Allegheny Health Network Team Develops Biomarker for Early Detection of Esophageal Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Cancer Classification System Might Boost Patient Outcomes
(Date:3/24/2017)... ... 24, 2017 , ... Northridge dentists, Dr. Michel ... sleep apnea and TMJ at their office. TMJ, or temporomandibular joint disorder, has ... type, is increasingly being treated at dental offices with newly developed procedures and ...
(Date:3/24/2017)... ... ... who like to educate themselves on current issues and who enjoy gaining knowledge on ... to appreciate and love the "Informed" series, hosted by Rob Lowe. A new ... the world. , Running for charity has become a multi-million dollar enterprise ...
(Date:3/24/2017)... ... 24, 2017 , ... Judy Buchanan, co-owner of Serenity Natural ... Judy says, “I am passionate about sharing Reiki as a holistic, complementary therapy ... challenging time.” , A Certified Medical Reiki™ Master trained by Raven Keys Medical ...
(Date:3/24/2017)... ... March 24, 2017 , ... “Vintage and Harvest A Cultivation ... and college Bible teacher residing in North Carolina with his wife, Anna Marie. He ... them with six grandchildren. David is also the author of “Shadow and Substance.” , ...
(Date:3/23/2017)... ... March 23, 2017 , ... In 2016 the World Health Organization ... could be four million Zika-related cases in the Americas within the next year. Lyme ... cases reported per year skyrocketing to an estimated 329,000. Yet, Zika, Lyme and other ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)...  HealthMine surveys with 9,250 insured consumers fielded from ... members want help from their plans in five key ... health, 2) help closing gaps in care, 3) better ... 5) relevant, real-time guidance. Meeting these needs is essential ... A Reason to Stay Engaged in ...
(Date:3/24/2017)... 23, 2017  Provectus Biopharmaceuticals, Inc. (OTCQB: PVCT, ... clinical-stage oncology and dermatology biopharmaceutical company, today disclosed ... Term Sheet (the "Definitive Financing") it entered into ... Company,s stockholders, who are referred to in the ... 8-K filed with the Securities and Exchange Commission. ...
(Date:3/24/2017)... The Board of Directors of Nordic Nanovector ASA ... the complete 2016 Annual Accounts with notes. The report is ... in the section Investor Relations/Reports and presentations/Annual Reports. ... For further information, ... Officer Cell: +47-91-51-95-76 Email: ir@nordicnanovector.com Media ...
Breaking Medicine Technology: